Find Topic

Medico Legal & Pharmaceutical Law

Rare cancers: Measuring success in small doses

Rare cancers "is a term which encompasses both rare and less common cancers. A rare cancer is defined as a type of cancer that has less than 6 incidences per year per 100,000 population. A less common cancer is defined as one that has between 6 and 12 incidences per year per 100,000 population" (Cancer…

10 Feb 2015, by Informa Australia

Medico Legal & Pharmaceutical Law

The black, white and grey area of assisted suicide

Suicide has become a prominent public health concern throughout Australia with 2,535 individuals choosing to take their life in 2012, while the national average over the past five years has reached 2,415 (Australian Bureau of Statistics, 2012). Such numbers have caused both Australian medical and legal professional to enter a dialogue surrounding the idea of…

7 Jan 2015, by Informa Australia

Medico Legal & Pharmaceutical Law

Raising awareness of Fetal Alcohol Spectrum Disorder (FASD)

FASD is a brain injury too. Our 2nd Annual National Acquired Brain Injury conference in Sydney featured on interactive panel discussion on the developments and implications for Australia of FASD. The discussion featured Vicki Russell, CEO, National Organisation for Fetal Alcohol Spectrum Disorders, Prof Heather Douglas from TC Beirne School of Law at the University…

17 Dec 2014, by Informa Australia

Medico Legal & Pharmaceutical Law

Debating drug pricing, regulation and industry transparency

Pharmaceutical companies, law firms, government departments, associations and consultants convened at the Sydney Harbour Marriott on 29th and 30th May 2014, for the 7th Annual Pharmaceutical Law Conference. Over this jam-packed two-day event, discussion centred on a selection of pivotal issues impacting the industry including pharmaceutical law reforms, Intellectual Property, evaluation of the competitive landscape and industry…

16 Jun 2014, by Informa Australia

Medico Legal & Pharmaceutical Law

Pharmaceutical industry slams impact of Commission of Audit

The recently released National Commission of Audit has been met with hostile reception from the healthcare industry, particularly from the pharmaceutical sector, as its recommendations threaten to further complicate an already complex profession. According to a May 1 statement from the Pharmaceutical Society of Australia (PSA), one of the recommendations of the Commission of Audit…

12 May 2014, by Informa Australia

Medico Legal & Pharmaceutical Law

Close-Up: Professor John Skerritt

Prof. John Skerritt joined the Australian Therapeutic Goods Administration (TGA) as its National Manager in May 2012.  He is also a member of the Executive of the Australian Department of Health.  TGA is responsible for regulating therapeutic goods including prescription, over the counter and complementary medicines, medical devices, blood and blood products.  Prof. Skerritt is…

30 Apr 2014, by Informa Australia

Medico Legal & Pharmaceutical Law

EU Commission fighting anticompetitive agreements in pharmaceuticals

Harald Mische is an official at the European Commission’s Directorate General for Competition, where he currently forms part of the team in charge with antitrust enforcement in the pharma sector. He will be presenting at the 2014 Pharmaceutical Law conference, to be held on the 29-30 May in Sydney about competitive law enforcement in the…

18 Mar 2014, by Informa Australia

Medico Legal & Pharmaceutical Law

Close-Up: Dr. Donella Piper

Donella Piper is a lecturer in Health Management at the University of New England.  She is a social scientist who also has a legal background. Donella will be co-presenting a case study on “A Pilot Project Investigating the Potential Role, Impact and Regulation of Patient Advocates in the Australian Health Care System” at the 23rd annual…

10 Mar 2014, by Informa Australia
Page  of 2

Get all the latest on Informa news and events

Informa Australia is the nation's leading event organiser. Our events comprise of large scale exhibitions, industry conferences and highly specialised corporate training.

Find out more


Join Our Newsletter Informa Insights

Stay up-to-date with all the latest
updates, upcoming events & more.